Home > Qtrly Results > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹805 Cr ₹957 Cr ₹762 Cr ₹787 Cr ₹802 Cr ₹917 Cr ₹745 Cr ₹810 Cr
Expenses ₹587 Cr ₹668 Cr ₹618 Cr ₹618 Cr ₹574 Cr ₹660 Cr ₹596 Cr ₹634 Cr
Operating Income ₹218 Cr ₹289 Cr ₹144 Cr ₹170 Cr ₹229 Cr ₹257 Cr ₹149 Cr ₹175 Cr
Other Income ₹28 Cr ₹28 Cr ₹36 Cr ₹28 Cr ₹23 Cr ₹22 Cr ₹28 Cr ₹19 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Depreciation ₹17 Cr ₹18 Cr ₹16 Cr ₹17 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹15 Cr
Profit Before Tax ₹65 Cr ₹299 Cr ₹181 Cr ₹190 Cr ₹224 Cr ₹262 Cr ₹160 Cr ₹208 Cr
Profit After Tax ₹46 Cr ₹218 Cr ₹132 Cr ₹133 Cr ₹165 Cr ₹193 Cr ₹116 Cr ₹-55 Cr
EPS ₹2.70 ₹12.84 ₹7.81 ₹7.88 ₹9.71 ₹11.42 ₹7.04 ₹71.96
Industry Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS 10.5% 3.8% 67.8%
SUN PHARMACEUTICAL INDUSTRIES -0.1% -2.8% 50.3%
CIPLA 4.5% -3.1% 52.8%
DR REDDYS LABORATORIES 4.6% 1.4% 22.2%
ZYDUS LIFESCIENCES 3.1% -4.1% 80.4%
DIVIS LABORATORIES 4.7% 10.8% 18.1%
MANKIND PHARMA 2.7% 12.4% NA
TORRENT PHARMACEUTICALS 6.1% 5.3% 66.2%
LUPIN 3.1% -1.1% 127.4%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-15.85 %

Y-o-Y

0.37 %

Quarters Revenues % Change
Dec2023 ₹805 Cr
-15.85
Sep2023 ₹957 Cr
25.65
Jun2023 ₹762 Cr
-3.28
Mar2023 ₹787 Cr
-1.85
Dec2022 ₹802 Cr
-12.50
Sep2022 ₹917 Cr
23.05
Jun2022 ₹745 Cr
-7.97
Mar2022 ₹810 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-24.67 %

Y-o-Y

-4.65 %

Quarters Operating Profit % Change
Dec2023 ₹218 Cr
-24.67
Sep2023 ₹289 Cr
101.20
Jun2023 ₹144 Cr
-15.24
Mar2023 ₹170 Cr
-25.78
Dec2022 ₹229 Cr
-10.99
Sep2022 ₹257 Cr
72.53
Jun2022 ₹149 Cr
-15.01
Mar2022 ₹175 Cr -
Operating Margins
Q-o-Q

-10.48 %

Y-o-Y

-5.02 %

Quarters Operating Margin% % Change
Dec2023 27.08%
-10.48
Sep2023 30.25%
60.14
Jun2023 18.89%
-12.38
Mar2023 21.56%
-24.38
Dec2022 28.51%
1.75
Sep2022 28.02%
40.17
Jun2022 19.99%
-7.62
Mar2022 21.64% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-78.98 %

Y-o-Y

-72.22 %

Quarters Profit After Tax % Change
Dec2023 ₹46 Cr
-78.98
Sep2023 ₹218 Cr
64.47
Jun2023 ₹132 Cr
-0.88
Mar2023 ₹133 Cr
-18.92
Dec2022 ₹165 Cr
-14.92
Sep2022 ₹193 Cr
66.41
Jun2022 ₹116 Cr
Positive
Mar2022 ₹-55 Cr -
PAT Margins
Q-o-Q

-75.01 %

Y-o-Y

-72.31 %

Quarters PAT Margin(%) % Change
Dec2023 5.68 %
-75.01
Sep2023 22.73 %
30.93
Jun2023 17.36 %
2.48
Mar2023 16.94 %
-17.41
Dec2022 20.51 %
-2.80
Sep2022 21.1 %
35.26
Jun2022 15.6 %
Positive
Mar2022 -6.75 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-78.97 %

Y-o-Y

-72.19 %

Quarters EPS % Change
Dec2023 ₹2.7
-78.97
Sep2023 ₹12.84
64.40
Jun2023 ₹7.81
-0.89
Mar2023 ₹7.88
-18.85
Dec2022 ₹9.71
-14.97
Sep2022 ₹11.42
62.22
Jun2022 ₹7.04
-90.22
Mar2022 ₹71.96 -

You may also like the below Video Courses